Top

Nederlands Tijdschrift voor Evidence Based Practice

Gepubliceerd in:

01-02-2008 | Wetenschap kritisch bekeken

Clinical pharmacists and inpatient medical care: a systematic review1)

Auteur: Berry Middel

Gepubliceerd in: Nederlands Tijdschrift voor Evidence Based Practice | Uitgave 1/2008

Samenvatting

De rol van de klinisch farmacoloog (KF) in de zorg voor ziekenhuis- en verpleeghuispatiënten is in de laatste decennia veranderd met een toegenomen nadruk op interdisciplinaire samenwerking en interactie met de patiënt. De rol van de klinisch farmacoloog verschilt van de traditionele apotheker in de directe samenwerking met zowel medische professionals als patiënten en beperkt zich niet meer tot het louter verstrekken van geneesmiddelen.

vorige artikel De Multiple Sclerosis Impact Profile (MSIP): een meetinstrument voor MS-gerelateerde functioneringsproblemen en de beleving daarvan

volgende artikel A randomised controlled trial of the effect of continuous electronic physiological monitoring on the adverse event rate in high risk medical and surgical patients1)

Kaboli PJ, Hoth AB, McClimon BJ, Schnipper JL. Clinical Pharmacists and Inpatient Medical Care. A systematic review. Arch Intern Med 2006;166:955-964

Academic Health Centers. Leading Change in the21st Century. Washington, DC: National Academy Press; 2003.

Kohn LT, Corrigan JM, Donaldson MS. To Err Is Human. Washington, DC: National Academy Press;2000.

Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit [published correction appears in JAMA. 2000;283:1293]. JAMA.1999;282:267-270.

Smythe MA, Shah PP, Spiteri TL, Lucarotti RL,Begle RL. Pharmaceutical care in medical progressive care patients. Ann Pharmacother. 1998;32:294-299.

Bjornson DC, Hiner WO Jr, Potyk RP, et al. Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm. 1993;50:1875-1884.

Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health System Pharm. 2002;59: 2089-2092.

Clapham CE, Hepler CD, Reinders TP, Lehman ME, Pesko L. Economic consequences of two druguse control systems in a teaching hospital. Am J Hosp Pharm. 1988;45:2329-2340.

Haig GM, Kiser LA. Effect of pharmacist participation on a medical team on costs, charges, and length of stay. Am J Hosp Pharm. 1991;48:1457- 1462.

Boyko WL Jr, Yurkowski PJ, Ivey MF, Armitstead JA, Roberts BL. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital. Am J Health Syst Pharm. 1997; 54:1591-1595.

Kucukarslan SN, Peters M, Mlynarek M, Nafziger DA. Pharmacists on rounding teams reduce preventable adverse drug events in hospital general medicine units. Arch Intern Med. 2003;163: 2014-2018.

Owens NJ, Sherburne NJ, Silliman RA, Fretwell MD. The Senior Care Study: the optimal use of medications in acutely ill older patients. JAmGeriatr Soc. 1990;38:1082-1087.

Canales PL, Dorson PG, Crismon ML. Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm. 2001;58:1309-1316.

Nester TM, Hale LS. Effectiveness of a pharmacist acquired medication history in promoting patient safety. Am J Health Syst Pharm. 2002; 59:2221-2225.

Stowasser DA, Collins DM, Stowasser M. A randomized controlled trial of medication liaison services, I: patient outcomes. J Pharm Pract Res. 2002;32:133-140.

Smith L, McGowan L, Moss-Barclay C, Wheater J, Knass D, Chrystyn H. An investigation of hospital generated pharmaceutical care when patients are discharged home from hospital.Br J Clin Pharmacol. 1997;44:163-165.

Bolas H, Brookes K, Scott M, McElnay J. Evaluation of a hospital-based community liaison pharmacy service in Northern Ireland. Pharm World Sci. 2004;26:114-120.

Williford SL, Johnson DF. Impact of pharmacist counseling on medication knowledge and compliance. Mil Med. 1995;160:561-564.

Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients’ compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307-315.

Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists’ consultations on physicians’ geriatric drug prescribing: a randomized controlled trial. Med Care. 1992;30:646-658.

Johnston M, Clarke A, Mundy K, Cromarty E, Ridout K. Facilitating comprehension of discharge medication in elderly patients. Age Ageing. 1986; 15:304-306.

Nazareth I, Burton A, Shulman S, Smith P, Haines A, Timberal H. A pharmacy discharge plan for hospitalized elderly patients: a randomized controlled trial. Age Ageing. 2001;30:33-40.

Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol. 2002;54:657- 664.

Schnipper JL, Kirwin JL, Cotugno MC, et al.Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166:565-571.

Mamdani MM, Racine E, McCreadie S, et al. Clinical and economic effectiveness of an inpatient anticoagulation service. Pharmacotherapy. 1999;19:1064-1074.

Dager WE, Branch JM, King JH, et al. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service. Ann Pharmacother. 2000; 34:567-572.

Ellis RF, Stephens MA, Sharp GB. Evaluation of a pharmacy-managed warfarin-monitoring service to coordinate inpatient and outpatient therapy. Am J Hosp Pharm. 1992;49:387-394.

Tschol N, Lai DK, Tilley JA, Wong H, Brown GR. Comparison of physician- and pharmacistmanaged warfarin sodium treatment in open heart surgery patients. Can J Cardiol. 2003;19:1413- 1417.

Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med. 1997;157: 1689-1694.

Gentry CA, Greenfield RA, Slater LN, Wack M, Huycke MM. Outcomes of an antimicrobial control program in a teaching hospital. Am J Health Syst Pharm. 2000;57:268-274.

Bailey TC, Ritchie DJ, McMullin ST, et al. A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions. Pharmacotherapy. 1997;17:277-281.

Gums JG, YanceyRWJr, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy. 1999;19:1369-1377.

Destache CJ, Meyer SK, Bittner MJ, Hermann KG. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides: a costbenefit analysis. Ther Drug Monit. 1990;12: 419-426.

Destache CJ, Meyer SK, Padomek MT, Ortmeier BG. Impact of a clinical pharmacokinetic service on patients treated with aminoglycosides for gramnegative infections. DICP. 1989;23:33-38.

Welty TE, Copa AK. Impact of vancomycin therapeutic drug monitoring on patient care. Ann Pharmacother. 1994;28:1335-1339.

Burton ME, Ash CL, Hill DP, Handy T, Shepherd MD, Vasko MR. A controlled trial of the cost benefit of computerized bayesian aminoglycoside administration. Clin Pharmacol Ther. 1991;49: 685-694.

Winter ME, Herfindal ET, Bernstein LR. Impact of decentralized pharmacokinetics consultation service. Am J Hosp Pharm. 1986;43:2178-2184.

Leehey DJ, Braun BI, Tholl DA, et al. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. J Am Soc Nephrol. 1993;4:81-90.

Wing DS, Duff HJ. The impact of a therapeutic drug monitoring program for phenytoin. Ther Drug

Titel: Clinical pharmacists and inpatient medical care: a systematic review1)
Auteur: Berry Middel
Publicatiedatum: 01-02-2008
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Nederlands Tijdschrift voor Evidence Based Practice / Uitgave 1/2008
Print ISSN: 1572-2082
Elektronisch ISSN: 1876-8806
DOI: https://doi.org/10.1007/BF03077153

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2008

A randomised controlled trial of the effect of continuous electronic physiological monitoring on the adverse event rate in high risk medical and surgical patients1)

The impact of electronic health records on time efficiency of physicians and nurses: a systematic review1)

Systematisch literatuuronderzoek van gerandomiseerde onderzoeken (deel 2)

EBP: beginnen bij de vraag of bij het antwoord?

Een checklist voor het gehele chirurgische traject

Veiligheid